Seed IP partners, Chandra E. Eidt and Jeffrey C. Pepe, Ph.D., are moderating a panel at the upcoming BIO IP Counsels Committee (BIO-IPCC) conference, taking place April 8-10 in Denver, Colorado. The panel, sponsored by Seed IP Law Group, is entitled, “Biosimilars: Where are we now and where are we going?,” and is set for Wednesday, April 10 from 8:30-9:45 a.m. This panel will discuss the evolving landscape of US and EP biosimilar approvals and patent considerations. Also to be discussed are biosimilar patent prosecution and litigation strategies, as well as risk assessment and management for developing biosimilars.

Speakers on this panel are:
Michael W. Johnson, Partner, Willkie Farr & Gallagher LLP
Gonzalo Merino, Ph.D., J.D., Vice President, Chief Intellectual Property Counsel, Regeneron Pharmaceuticals, Inc.
Dr. Leonard L. Werner-Jones, Partner, European Patent Attorney, Hoffmann Eitle

Read more about Chandra E. Eidt

Post-Panel Write-Up | INTA Panel: ‘Scams, Frauds, and Other Misdeeds on the Internet’ with Seed IP’s Russ Pangborn
Seed IP Law Group on list of Top 25 Growing Patent Firms From 2009 to 2018
Seed IP Law Group Welcomes Associate Bobby Sahachartsiri
Seed IP Law Group Welcomes Associate Toby Ligon
More News & Events